Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS.
Bessesen
M T
MT
Miller
L A
LA
Cohn
D L
DL
Bartlett
S
S
Ellison
R T
RT
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy / Q000517:prevention & control*; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use
D015215:Zidovudine; D010419:Pentamidine; D013413:Sulfadoxine; D011739:Pyrimethamine